190 related articles for article (PubMed ID: 16571819)
1. Novel insights into the pathogenesis of the Graffi murine leukemia retrovirus.
Voisin V; Barat C; Hoang T; Rassart E
J Virol; 2006 Apr; 80(8):4026-37. PubMed ID: 16571819
[TBL] [Abstract][Full Text] [Related]
2. Graffi murine leukemia virus: molecular cloning and characterization of the myeloid leukemia-inducing agent.
Ru M; Shustik C; Rassart E
J Virol; 1993 Aug; 67(8):4722-31. PubMed ID: 8392610
[TBL] [Abstract][Full Text] [Related]
3. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
4. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H
Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406
[TBL] [Abstract][Full Text] [Related]
5. Oncogene activation in myeloid leukemias by Graffi murine leukemia virus proviral integration.
Denicourt C; Edouard E; Rassart E
J Virol; 1999 May; 73(5):4439-42. PubMed ID: 10196342
[TBL] [Abstract][Full Text] [Related]
6. Complete genome sequences of the two viral variants of the Graffi MuLV: phylogenetic relationship with other murine leukemia retroviruses.
Voisin V; Rassart E
Virology; 2007 May; 361(2):335-47. PubMed ID: 17208267
[TBL] [Abstract][Full Text] [Related]
7. Gene profiling of Graffi murine leukemia virus-induced lymphoid leukemias: identification of leukemia markers and Fmn2 as a potential oncogene.
Charfi C; Voisin V; Levros LC; Edouard E; Rassart E
Blood; 2011 Feb; 117(6):1899-910. PubMed ID: 21135260
[TBL] [Abstract][Full Text] [Related]
8. Gris1, a new common integration site in Graffi murine leukemia virus-induced leukemias: overexpression of a truncated cyclin D2 due to alternative splicing.
Denicourt C; Kozak CA; Rassart E
J Virol; 2003 Jan; 77(1):37-44. PubMed ID: 12477808
[TBL] [Abstract][Full Text] [Related]
9. A Moloney murine leukemia virus-based retrovirus with 4070A long terminal repeat sequences induces a high incidence of myeloid as well as lymphoid neoplasms.
Wolff L; Koller R; Hu X; Anver MR
J Virol; 2003 Apr; 77(8):4965-71. PubMed ID: 12663802
[TBL] [Abstract][Full Text] [Related]
10. Molecular and phylogenetic analysis of SRS 19-6 murine leukemia virus.
Bundy LM; Fan H
Virus Genes; 1999; 18(1):65-79. PubMed ID: 10334039
[TBL] [Abstract][Full Text] [Related]
11. Phenotypes of murine leukemia virus-induced tumors: influence of 3' viral coding sequences.
Ott DE; Keller J; Sill K; Rein A
J Virol; 1992 Oct; 66(10):6107-16. PubMed ID: 1326661
[TBL] [Abstract][Full Text] [Related]
12. Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies.
Largaespada DA
Leukemia; 2000 Jul; 14(7):1174-84. PubMed ID: 10914539
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.
Lawrenz-Smith SC; Massey AC; Innes DJ; Thomas CY
J Virol; 1994 Aug; 68(8):5174-83. PubMed ID: 8035516
[TBL] [Abstract][Full Text] [Related]
14. Enhancer mutations of Akv murine leukemia virus inhibit the induction of mature B-cell lymphomas and shift disease specificity towards the more differentiated plasma cell stage.
Sørensen KD; Kunder S; Quintanilla-Martinez L; Sørensen J; Schmidt J; Pedersen FS
Virology; 2007 May; 362(1):179-91. PubMed ID: 17258785
[TBL] [Abstract][Full Text] [Related]
15. Importance of receptor usage, Fli1 activation, and mouse strain for the stem cell specificity of 10A1 murine leukemia virus leukemogenicity.
Rodenburg M; Fischer M; Engelmann A; Harbers SO; Ziegler M; Löhler J; Stocking C
J Virol; 2007 Jan; 81(2):732-42. PubMed ID: 17079317
[TBL] [Abstract][Full Text] [Related]
16. Nuclear factors that bind to the U3 region of two murine myeloid leukemia-inducing retroviruses, Cas-Br-E and Graffi.
Barat C; Rassart E
Virology; 1998 Dec; 252(1):82-95. PubMed ID: 9875319
[TBL] [Abstract][Full Text] [Related]
17. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
[TBL] [Abstract][Full Text] [Related]
18. Effect of murine host genotype on MCF virus expression, latency, and leukemia cell type of leukemias induced by Friend murine leukemia helper virus.
Chesebro B; Portis JL; Wehrly K; Nishio J
Virology; 1983 Jul; 128(1):221-33. PubMed ID: 6308893
[TBL] [Abstract][Full Text] [Related]
19. Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties.
Audit M; Déjardin J; Hohl B; Sidobre C; Hope TJ; Mougel M; Sitbon M
J Virol; 1999 Dec; 73(12):10472-9. PubMed ID: 10559365
[TBL] [Abstract][Full Text] [Related]
20. Different abilities of Friend murine leukemia virus (MuLV) and Moloney MuLV to induce promonocytic leukemia are due to determinants in both psi-gag-PR and env regions.
Mukhopadhyaya R; Richardson J; Nazarov V; Corbin A; Koller R; Sitbon M; Wolff L
J Virol; 1994 Aug; 68(8):5100-7. PubMed ID: 7518530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
